Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues

Authors: Rhiannon Tudor Edwards, Joanna Mary Charles, Huw Lloyd-Williams

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

If Public Health is the science and art of how society collectively aims to improve health, and reduce inequalities in health, then Public Health Economics is the science and art of supporting decision making as to how society can use its available resources to best meet these objectives and minimise opportunity cost. A systematic review of published guidance for the economic evaluation of public health interventions within this broad public policy paradigm was conducted.

Methods

Electronic databases and organisation websites were searched using a 22 year time horizon (1990–2012). References of papers were hand searched for additional papers for inclusion. Government reports or peer-reviewed published papers were included if they; referred to the methods of economic evaluation of public health interventions, identified key challenges of conducting economic evaluations of public health interventions or made recommendations for conducting economic evaluations of public health interventions. Guidance was divided into three categories UK guidance, international guidance and observations or guidance provided by individual commentators in the field of public health economics. An assessment of the theoretical frameworks underpinning the guidance was made and served as a rationale for categorising the papers.

Results

We identified 5 international guidance documents, 7 UK guidance documents and 4 documents by individual commentators. The papers reviewed identify the main methodological challenges that face analysts when conducting such evaluations. There is a consensus within the guidance that wider social and environmental costs and benefits should be looked at due to the complex nature of public health. This was reflected in the theoretical underpinning as the majority of guidance was categorised as extra-welfarist.

Conclusions

In this novel review we argue that health economics may have come full circle from its roots in broad public policy economics. We may find it useful to think in this broader paradigm with respect to public health economics. We offer a 12 point checklist to support government, NHS commissioners and individual health economists in their consideration of economic evaluation methodology with respect to the additional challenges of applying health economics to public health.
Appendix
Available only for authorised users
Literature
4.
go back to reference Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A: Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009, 93: 85-92. 10.1016/j.healthpol.2009.07.012.CrossRefPubMed Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A: Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009, 93: 85-92. 10.1016/j.healthpol.2009.07.012.CrossRefPubMed
5.
go back to reference Payne K, McAllister M, Davies LM: Valuing the economic benefits of complex interventions: when maximising health is not sufficient. Health Econ. 2012, doi:10.1002/hec.2795 [Published Online First] Payne K, McAllister M, Davies LM: Valuing the economic benefits of complex interventions: when maximising health is not sufficient. Health Econ. 2012, doi:10.1002/hec.2795 [Published Online First]
6.
go back to reference Coast J, Smith R, Lorgelly P: Should the capability approach be applied in health economics?. Health Econ. 2008, 17: 667-670. 10.1002/hec.1359.CrossRefPubMed Coast J, Smith R, Lorgelly P: Should the capability approach be applied in health economics?. Health Econ. 2008, 17: 667-670. 10.1002/hec.1359.CrossRefPubMed
9.
go back to reference Owen L, Morgan A, Fischer A, Ellis S, Hoy A, Kelly M: The cost-effectiveness of public health interventions. J Public Health. 2011, doi: 10.1093/pubmed/fdr075 [Published Online First] Owen L, Morgan A, Fischer A, Ellis S, Hoy A, Kelly M: The cost-effectiveness of public health interventions. J Public Health. 2011, doi: 10.1093/pubmed/fdr075 [Published Online First]
12.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrows C, Gøtzsche PC, Ioannidis JPA, Clarke M, Deveraux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009, 6: e1000100-10.1371/journal.pmed.1000100.CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrows C, Gøtzsche PC, Ioannidis JPA, Clarke M, Deveraux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009, 6: e1000100-10.1371/journal.pmed.1000100.CrossRefPubMedPubMedCentral
13.
go back to reference MacDonald G, O’Hara K: Ten elements of mental health, its promotion and demotion: implications for practice. 1998, London: Society of Health Education and Promotion Specialists MacDonald G, O’Hara K: Ten elements of mental health, its promotion and demotion: implications for practice. 1998, London: Society of Health Education and Promotion Specialists
14.
go back to reference Culyer AJ: The normative economics of health care finance and provision. Oxf Rev Econ Policy. 1989, 5: 34-58. 10.1093/oxrep/5.1.34.CrossRef Culyer AJ: The normative economics of health care finance and provision. Oxf Rev Econ Policy. 1989, 5: 34-58. 10.1093/oxrep/5.1.34.CrossRef
15.
go back to reference Sen AK: Commodities and Capabilities. 1985, Oxford: Oxford University Press Sen AK: Commodities and Capabilities. 1985, Oxford: Oxford University Press
18.
go back to reference Morris S, Devlin N, Parkin D: Economic Analysis in Healthcare. 2007, Chichester, UK: Wiley and Sons Morris S, Devlin N, Parkin D: Economic Analysis in Healthcare. 2007, Chichester, UK: Wiley and Sons
19.
go back to reference Gyrd-Hansen D: Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics. 2005, 23: 423-432. 10.2165/00019053-200523050-00002.CrossRefPubMed Gyrd-Hansen D: Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics. 2005, 23: 423-432. 10.2165/00019053-200523050-00002.CrossRefPubMed
20.
go back to reference Group EQL: EuroQoL—a new facility for the measurement of health related quality of life. Health Policy. 1990, 16: 199-208.CrossRef Group EQL: EuroQoL—a new facility for the measurement of health related quality of life. Health Policy. 1990, 16: 199-208.CrossRef
21.
go back to reference Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J: Developing attributes for a generic Quality of Life Measure for Older People: preferences or capabilities?. Soc Sci Med. 2006, 62: 1891-1901. 10.1016/j.socscimed.2005.08.023.CrossRefPubMed Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J: Developing attributes for a generic Quality of Life Measure for Older People: preferences or capabilities?. Soc Sci Med. 2006, 62: 1891-1901. 10.1016/j.socscimed.2005.08.023.CrossRefPubMed
24.
go back to reference Tarn TY, Smith MD: Pharmacoeconomic guidelines around the world. ISPOR Connections. 2004, 10: 4-5. Tarn TY, Smith MD: Pharmacoeconomic guidelines around the world. ISPOR Connections. 2004, 10: 4-5.
33.
go back to reference Sen AK: Capability and Well-being. The Quality of Life. Edited by: Nussbaum MC, Sen AK. 1993, Oxford: Clarendon Press Sen AK: Capability and Well-being. The Quality of Life. Edited by: Nussbaum MC, Sen AK. 1993, Oxford: Clarendon Press
34.
go back to reference Marsh K, Phillips CJ, Fordham R, Bertranou E, Hale J: Estimating cost-effectiveness in public health: a summary of modelling and valuation methods. Health Econ Rev. 2012, 2: doi:10.1186/2191-1991-2-17 [Published Online First] Marsh K, Phillips CJ, Fordham R, Bertranou E, Hale J: Estimating cost-effectiveness in public health: a summary of modelling and valuation methods. Health Econ Rev. 2012, 2: doi:10.1186/2191-1991-2-17 [Published Online First]
36.
go back to reference Williams A: Cost-benefit analysis: bastard science? And/or insidious poison in the body politick?. J Public Econ. 1972, 1: 199-225. 10.1016/0047-2727(72)90002-3.CrossRef Williams A: Cost-benefit analysis: bastard science? And/or insidious poison in the body politick?. J Public Econ. 1972, 1: 199-225. 10.1016/0047-2727(72)90002-3.CrossRef
37.
go back to reference Sackett DL, Rosenberg WMC, Muir Gray JA, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn't. BMJ. 1996, 312: 71-72. 10.1136/bmj.312.7023.71.CrossRefPubMedPubMedCentral Sackett DL, Rosenberg WMC, Muir Gray JA, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn't. BMJ. 1996, 312: 71-72. 10.1136/bmj.312.7023.71.CrossRefPubMedPubMedCentral
38.
go back to reference Williams A: Priorities and research strategy in health economics for the 1990. Health Econ. 1993, 2: 295-302. 10.1002/hec.4730020402.CrossRefPubMed Williams A: Priorities and research strategy in health economics for the 1990. Health Econ. 1993, 2: 295-302. 10.1002/hec.4730020402.CrossRefPubMed
39.
go back to reference Phelps CE: Perspectives in health economics. Health Econ. 1995, 4: 335-353. 10.1002/hec.4730040501.CrossRefPubMed Phelps CE: Perspectives in health economics. Health Econ. 1995, 4: 335-353. 10.1002/hec.4730040501.CrossRefPubMed
40.
go back to reference Fuchs VR: The future of health economics. J Health Econ. 2000, 19: 141-157. 10.1016/S0167-6296(99)00033-8.CrossRefPubMed Fuchs VR: The future of health economics. J Health Econ. 2000, 19: 141-157. 10.1016/S0167-6296(99)00033-8.CrossRefPubMed
41.
go back to reference Edwards RT: Paradigms and research programmes: is it time to move from health care economics to health economics?. Health Econ. 2001, 10: 635-649. 10.1002/hec.610.CrossRefPubMed Edwards RT: Paradigms and research programmes: is it time to move from health care economics to health economics?. Health Econ. 2001, 10: 635-649. 10.1002/hec.610.CrossRefPubMed
42.
go back to reference Chokshi DA, Farley TA: The cost-effectiveness of environmental approaches to disease prevention. N Engl J Med. 2012, 367: 295-297. 10.1056/NEJMp1206268.CrossRefPubMed Chokshi DA, Farley TA: The cost-effectiveness of environmental approaches to disease prevention. N Engl J Med. 2012, 367: 295-297. 10.1056/NEJMp1206268.CrossRefPubMed
43.
go back to reference Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. 2005, Oxford: Oxford University Press, 3 Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. 2005, Oxford: Oxford University Press, 3
44.
go back to reference Edwards RT, Céilleachair A, Bywater T, Hughes DA, Hutchings J: A parenting programme for children at risk of developing conduct disorder: a cost-effectiveness analysis. BMJ. 2007, 334: 682-10.1136/bmj.39126.699421.55.CrossRefPubMedPubMedCentral Edwards RT, Céilleachair A, Bywater T, Hughes DA, Hutchings J: A parenting programme for children at risk of developing conduct disorder: a cost-effectiveness analysis. BMJ. 2007, 334: 682-10.1136/bmj.39126.699421.55.CrossRefPubMedPubMedCentral
45.
go back to reference Edwards RT, Hounsome B, Linck P, Russell IT: Economic evaluation alongside pragmatic randomised trials: developing a Standard Operating Procedure for clinical trials units. Trials. 2008, 14: 64-65.CrossRef Edwards RT, Hounsome B, Linck P, Russell IT: Economic evaluation alongside pragmatic randomised trials: developing a Standard Operating Procedure for clinical trials units. Trials. 2008, 14: 64-65.CrossRef
46.
go back to reference Edwards RT, Neal RD, Linck P, Bruce N, Mullock L, Nelhans N, Pasterfield D, Russell D, Russell I, Woodfine L, on behalf of the CHARISMA study group: Enhancing ventilation in homes of children with asthma: cost-effectiveness study alongside randomised trial. Br J Gen Pract. 2011, 61: 733-741. 10.3399/bjgp11X606645.CrossRef Edwards RT, Neal RD, Linck P, Bruce N, Mullock L, Nelhans N, Pasterfield D, Russell D, Russell I, Woodfine L, on behalf of the CHARISMA study group: Enhancing ventilation in homes of children with asthma: cost-effectiveness study alongside randomised trial. Br J Gen Pract. 2011, 61: 733-741. 10.3399/bjgp11X606645.CrossRef
47.
go back to reference Murphy S, Edwards RT, Williams N, Raisenen L, Moore G, Linck P, Hounsome N, Ud Din N, Moore L: An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative. J Epidemiol Community Health. 2012, 66: 745-753. 10.1136/jech-2011-200689.CrossRefPubMedPubMedCentral Murphy S, Edwards RT, Williams N, Raisenen L, Moore G, Linck P, Hounsome N, Ud Din N, Moore L: An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative. J Epidemiol Community Health. 2012, 66: 745-753. 10.1136/jech-2011-200689.CrossRefPubMedPubMedCentral
Metadata
Title
Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues
Authors
Rhiannon Tudor Edwards
Joanna Mary Charles
Huw Lloyd-Williams
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-1001

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue